Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery
- PMID: 22820011
- DOI: 10.1016/j.ijbiomac.2012.07.014
Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery
Abstract
The aim of the study was to formulate and evaluate nanoparticles based on albumin to deliver 5-fluorouracil. The nanoparticles were prepared by coacervation method. The nanoparticles were characterized for particle size, surface charge, size distribution and drug loading capacity. The drug loading capacity varied from 4.22% to 19.8% (w/w). The mean particle size was 141.9 nm and surface charge was -30.3 mV. The drug loaded particles exerted a bi-phasic release pattern with an initial burst effect followed by a sustained release in pH 7.4 phosphate buffer. The drug release was first order diffusion controlled and the mechanism was Fickian. The drug loaded nanoparticles showed superior cytotoxicity when compared to the free drug.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Development of albumin-based nanoparticles for the delivery of abacavir.Int J Biol Macromol. 2015 Nov;81:763-7. doi: 10.1016/j.ijbiomac.2015.09.015. Epub 2015 Sep 10. Int J Biol Macromol. 2015. PMID: 26365020
-
Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.Drug Dev Ind Pharm. 2011 Oct;37(10):1170-80. doi: 10.3109/03639045.2011.563781. Epub 2011 Mar 31. Drug Dev Ind Pharm. 2011. PMID: 21449822
-
Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.Carbohydr Polym. 2013 Oct 15;98(1):870-6. doi: 10.1016/j.carbpol.2013.06.064. Epub 2013 Jul 5. Carbohydr Polym. 2013. PMID: 23987423
-
Albumin-based nanoparticles as potential controlled release drug delivery systems.J Control Release. 2012 Jan 30;157(2):168-82. doi: 10.1016/j.jconrel.2011.07.031. Epub 2011 Aug 1. J Control Release. 2012. PMID: 21839127 Review.
-
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.Eur J Pharm Biopharm. 2008 May;69(1):1-9. doi: 10.1016/j.ejpb.2007.08.001. Epub 2007 Aug 7. Eur J Pharm Biopharm. 2008. PMID: 17826969 Review.
Cited by
-
Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.Cancer Biol Ther. 2012 Dec;13(14):1407-16. doi: 10.4161/cbt.22001. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954702 Free PMC article.
-
Nanomedicine to deliver biological macromolecules for treating COVID-19.Vaccine. 2022 Jun 23;40(29):3931-3941. doi: 10.1016/j.vaccine.2022.05.068. Epub 2022 May 30. Vaccine. 2022. PMID: 35660038 Free PMC article. Review.
-
Factors Affecting the Synthesis of Bovine Serum Albumin Nanoparticles Using the Desolvation Method.Nanotechnol Sci Appl. 2024 Jan 31;17:21-40. doi: 10.2147/NSA.S441324. eCollection 2024. Nanotechnol Sci Appl. 2024. PMID: 38314401 Free PMC article. Review.
-
Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats.PLoS One. 2020 Aug 21;15(8):e0237929. doi: 10.1371/journal.pone.0237929. eCollection 2020. PLoS One. 2020. Retraction in: PLoS One. 2023 Nov 2;18(11):e0294102. doi: 10.1371/journal.pone.0294102. PMID: 32822403 Free PMC article. Retracted.
-
Nanotechnology for the Diagnosis and Treatment of Liver Cancer.Int J Nanomedicine. 2024 Dec 24;19:13805-13821. doi: 10.2147/IJN.S490661. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39735328 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources